The Annals of pharmacotherapy
Evaluation of the Use of Primary Prevention Aspirin in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant for Stroke Prevention.
Storee A Yzaguirre, Matthew R Rockhold, Thomas W Szymanski, Lauren Kunkel, Megan Vaughan, Seher Berzingi, Jordan L Lacoste
Published: 202510.1177/10600280251401892
Abstract
BACKGROUND: Current guidelines advise against use of aspirin for primary prevention of atherosclerotic cardiovascular disease (ASCVD) in patients with increased bleeding risk, including use of anticoagulation. However, limited data exist regarding sa…
Preview only. Read the full abstract at the source